About SeraCare Life Sciences (NASDAQ:SRLS)
SeraCare Life Sciences, Inc. (SeraCare) serves the global life sciences industry by providing products and services to facilitate the discovery, development and production of human and animal diagnostics and therapeutics. The Company's portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, bio banking and contract research services. It operates two segments: Diagnostic and Biopharmaceutical Products, and BioServices. The Diagnostic & Biopharmaceutical Products segment includes two types of products: controls and panels. The Bio Services segment includes bio banking, sample processing and testing services for research and clinical trials, and contract research services in molecular biology, virology, immunology and biochemistry.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:SRLS
CUSIPN/A
Phone+1-508-2446400
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
SeraCare Life Sciences (NASDAQ:SRLS) Frequently Asked Questions
What is SeraCare Life Sciences' stock symbol?
SeraCare Life Sciences trades on the NASDAQ under the ticker symbol "SRLS."
Who are some of SeraCare Life Sciences' key competitors?
Some companies that are related to SeraCare Life Sciences include Apple (AAPL), Alphabet (GOOGL), Alphabet (GOOG), Amazon.com (AMZN), Microsoft (MSFT), Facebook (FB), Intel (INTC), Cisco Systems (CSCO), Comcast (CMCSA), PepsiCo (PEP), Netflix (NFLX), Nvidia (NVDA), Amgen (AMGN), Adobe Systems (ADBE), Booking (BKNG), Texas Instruments (TXN), Broadcom (AVGO) and Gilead Sciences (GILD).
Has SeraCare Life Sciences been receiving favorable news coverage?
Press coverage about SRLS stock has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. SeraCare Life Sciences earned a media sentiment score of 0.20 on Accern's scale. They also gave news headlines about the company an impact score of 45.38 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
How do I buy shares of SeraCare Life Sciences?
Shares of SRLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact SeraCare Life Sciences?
SeraCare Life Sciences' mailing address is 37 Birch St, MILFORD, MA 01757-5501, United States. The company can be reached via phone at +1-508-2446400.
MarketBeat Community Rating for SeraCare Life Sciences (SRLS)
MarketBeat's community ratings are surveys of what our community members think about SeraCare Life Sciences and other stocks. Vote "Outperform" if you believe SRLS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRLS will underperform the S&P 500 over the long term. You may vote once every thirty days.
SeraCare Life Sciences (NASDAQ:SRLS) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/22/2016 forward)
SeraCare Life Sciences (NASDAQ:SRLS) Earnings History and Estimates Chart
SeraCare Life Sciences (NASDAQ SRLS) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 2/10/2012 | Q1 2012 | $0.04 | $0.07 | | | View | N/A |  |
| 11/17/2011 | Q4 2011 | $0.02 | ($0.04) | | | View | N/A | |
| 7/26/2011 | Q3 2011 | $0.07 | $0.03 | | | View | N/A | |
| 5/12/2011 | Q2 2011 | $0.06 | $0.07 | | | View | N/A | |
| 2/11/2011 | Q1 2011 | $0.08 | $0.04 | | | View | N/A | |
| 12/1/2010 | Q4 2010 | $0.08 | $0.11 | | | View | N/A | |
| 8/11/2010 | Q3 2010 | $0.12 | $0.07 | | | View | N/A | |
| 4/29/2010 | Q2 2010 | $0.09 | $0.11 | | | View | N/A | |
| 2/9/2010 | Q1 2010 | | $0.07 | | | View | N/A | |
| 11/19/2009 | Q4 2009 | | $0.08 | | | View | N/A | |
| 8/11/2009 | Q3 2009 | | $0.04 | | | View | N/A | |
| 5/12/2009 | Q2 2009 | | ($0.03) | | | View | N/A | |
| 2/17/2009 | Q1 2009 | | ($0.10) | | | View | N/A | |
| 12/8/2008 | Q4 2008 | | ($0.56) | | | View | N/A | |
| 5/15/2008 | Q2 2008 | | ($0.02) | | | View | N/A | |
| 2/14/2008 | Q1 2008 | | ($0.04) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
SeraCare Life Sciences (NASDAQ:SRLS) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
SeraCare Life Sciences (NASDAQ SRLS) Insider Trading and Institutional Ownership History
SeraCare Life Sciences (NASDAQ SRLS) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
SeraCare Life Sciences (NASDAQ SRLS) News Headlines
| Source: |
|
No headlines for this company have been tracked by MarketBeat.com
SeraCare Life Sciences (NASDAQ:SRLS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
SeraCare Life Sciences (NASDAQ:SRLS) Income Statement, Balance Sheet and Cash Flow Statement
SeraCare Life Sciences (NASDAQ SRLS) Stock Chart for Sunday, April, 22, 2018
Loading chart…
